MAPT and Alzheimer disease: Our main findings were: i) a significant increase in CSF t-α-syn levels in AD patients with respect to control subjects; ii) no significant change in CSF o- or p-S129-α-syn levels in AD patients; and iii) a significant correlation of t-α-syn levels with tau species and MMSE in the AD group.